Carregant...
Zoledronic Acid for Treatment of Low Bone Mineral Density in Patients with Beta Thalassemia Major
To determine the efficacy of zoledronic acid (ZA) in thalassemia major associated low bone mineral density. Prospective, open label, single arm trial. Bone mineral density (BMD) at lumbar, hip and forearm region were performed at baseline and after 1 year of therapy. Initial, 9 patients received a f...
Guardat en:
| Publicat a: | Indian J Hematol Blood Transfus |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer India
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6186220/ https://ncbi.nlm.nih.gov/pubmed/30369735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-018-0953-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|